Eli Lilly October 27, 2020 3:40 pm US Officials Cut Short COVID-19 Antibody Trial U.S. regulators have ended one of Eli Lilly’s COVID-19 antibody trials early after data suggested the drug was “unlikely to help” coronavirus patients recover. US & World Videos 1:07 Britney Spears spotted as authorities respond to alleged hotel incident 2:15 Prince William and Kate Middleton ‘going through hell,' friend claims (report) 8:01 Lady Gaga's outfit changes, Rihanna's bold looks and more iconic Met Gala moments 1:59 TikTok's Maddy Baloy dead at 26: Gordon Ramsay and Tay Lautner pay tribute 3:04 Progress being made on demolition of overpass on I-95 in Norwalk